News

Filter by Category

Filter by Program

Filter by Date

May 2, 2012

Renewed Focus on Tuberculosis Holds Promise for New Treatments

FDA approved rifampin for the treatment of tuberculosis (TB) in 1971, the same year Intel Corporation invented the first microproc

April 25, 2012

Re: the April 19 article “Vast study advances breast cancer fight.”

April 24, 2012

WASHINGTON–(BUSINESS WIRE)– The Association of Clinical Research Organizations (ACRO) today provided the FDA with a nu

April 21, 2012

The Critical path Institute (C-Path), the US Food and Drug Administration (FDA)-supported public-private initiative working to adv

April 18, 2012

Your doctor may soon – perhaps in a year – be able to order up a test to map out your entire genome, or genetic bluepr

April 18, 2012

April 15, 2012

I saw a presentation yesterday by Carolyn Compton, the new head of C-PATH, the critical path institute located in Tucson, AZ. This

April 14, 2012

Critical Path Institute (C-Path) has announced that Steven T. Broadbent has been chosen as the next chief operating officer of C-P

April 1, 2012

C-Path’s work was positively acknowledged by Dr. Janet Woodcock during the April 18 House Energy and Commerce Committee Hear

March 25, 2012

Critical Path Institute (C-Path) is proud to welcome four new board members who were recently elected to serve three-year terms (2